Product
AR101
3 clinical trials
1 indication
Indication
Peanut AllergyClinical trial
A Multicenter, Open-Label, Longer-Term Study of AR101 Characterized Oral Desensitization Immunotherapy in Subjects Who Participated in a Prior AR101 StudyStatus: Completed, Estimated PCD: 2023-04-27
Clinical trial
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study in Pediatric Subjects With Peanut Allergy to Evaluate the Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)Status: Completed, Estimated PCD: 2020-10-16
Clinical trial
Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)Status: Completed, Estimated PCD: 2022-07-05